Stay updated on Pneumococcal Vaccination in Myeloma Patients on Novel Agents Clinical Trial
Sign up to get notified when there's something new on the Pneumococcal Vaccination in Myeloma Patients on Novel Agents Clinical Trial page.

Latest updates to the Pneumococcal Vaccination in Myeloma Patients on Novel Agents Clinical Trial page
- Check7 days agoChange DetectedScreenshots show no significant changes to the study details, eligibility criteria, or layout; the page content and purpose remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check14 days agoNo Change Detected
- Check36 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference4%

- Check43 days agoChange Detected- Updated terminology from 'Plasma cell myeloma' to 'Multiple myeloma'. - Added new version tag 'Revision: v3.1.0'. - Removed outdated items: 'Vaccines, Combined', 'Heptavalent Pneumococcal Conjugate Vaccine', and 'Revision: v3.0.2'.SummaryDifference0.6%

- Check57 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The Back to Top element was removed, with no substantive changes to core content.SummaryDifference0.2%

- Check65 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

- Check72 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with additional related medical topics and publications, while removing some previous location details and specific drug information.SummaryDifference11%

Stay in the know with updates to Pneumococcal Vaccination in Myeloma Patients on Novel Agents Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pneumococcal Vaccination in Myeloma Patients on Novel Agents Clinical Trial page.